Christina A. Sheil, MD, explains why polypharmacy has become one of the most significant challenges in modern healthcare.
There is new evidence suggesting therapy may lead to higher recovery rates than medication in people over 60 who experience anxiety disorders, says Associate Professor Carly Johnco. Anxiety disorders ...
On Friday, the fledgling field of psychedelic medicine suffered a major setback. The FDA declined to approve MDMA-assisted therapy for PTSD, instead asking the drugmaker Lykos Therapeutics to conduct ...
If you have more than one chronic medical condition that you take medication for, your Part D plan or bundled plan provider may automatically enroll you for medication therapy management. If you live ...
Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.
Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of ...
PsyPost on MSN
Antidepressants and talk therapy show similar results, but medication leads in severe depression cases
Science and Practice suggests that while antidepressants and short-term psychodynamic therapy both help alleviate depression, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results